← Leaderboards
Arif Yurdagul
Columbia University Health Sciences
$3,430,427
Attributed
$3,430,427
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2019–25$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,430,427 · 4
By mechanism
R01$2,347,979 · 2
R00$747,000 · 1
K99$335,448 · 1
Top collaborators
No co-investigators on record.
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Alan Richard Tall$42,229,886
- Ira A Tabas$44,847,082
- Henry N Ginsberg$119,772,603
- Muredach P Reilly$136,077,018
- Lars F Berglund$52,226,926
Others in their field
Other Emerging Leaders on “Atherosclerosis”
- Bing Yu · University Of Tx Md Anderson Can Ctr$10,701,288
- Badri N Vardarajan · University Of Miami School Of Medicine$10,244,025
- Pradeep Natarajan · Massachusetts General Hospital$9,255,801
- Jose Gutierrez · Columbia University Health Sciences$7,601,653
- Stephen P Juraschek · Beth Israel Deaconess Medical Center$6,842,455
- William Raymond Lagor · Baylor College Of Medicine$6,500,004
Research focus
AtherosclerosisMyocardial InfarctionArterial Fatty StreakInflammationLinkMacrophagePathway InteractionsStrokeRuptureEnzymesProgramsEventPutrescineMetabolic PathwayLeadCardiovascular SystemOrnithine DecarboxylaseIn VivoDetection Of NutrientApoptoticCuesImpairmentMutantCholesterol
Grant awards (9)
Nutrient Sensing of Apoptotic Cells by Macrophages Resolves Inflammation, Drives Atherosclerosis Regression, and Promotes Features of Plaque Instability$659,441
R01 · FY2025 · HL · contact PI
Dysregulations in Polyamine Metabolism During Atherosclerosis$566,623
R01 · FY2025 · HL · contact PI
Dysregulations in Polyamine Metabolism During Atherosclerosis$555,292
R01 · FY2024 · HL · contact PI
Dysregulations in Polyamine Metabolism During Atherosclerosis$566,623
R01 · FY2023 · HL · contact PI
Processing of Apoptotic Cell-Derived Cargo by Macrophages Continues Efferocytosis and Drives Atherosclerosis Regression$249,000
R00 · FY2023 · HL · contact PI
Processing of Apoptotic Cell-Derived Cargo by Macrophages Continues Efferocytosis and Drives Atherosclerosis Regression$249,000
R00 · FY2022 · HL · contact PI
Processing of Apoptotic Cell-Derived Cargo by Macrophages Continues Efferocytosis and Drives Atherosclerosis Regression$249,000
R00 · FY2021 · HL · contact PI
Processing of Apoptotic Cell-Derived Cargo by Macrophages Continues Efferocytosis and Drives Atherosclerosis Regression$167,724
K99 · FY2020 · HL · contact PI
Processing of Apoptotic Cell-Derived Cargo by Macrophages Continues Efferocytosis and Drives Atherosclerosis Regression$167,724
K99 · FY2019 · HL · contact PI